Plasticity of mesangial cells: A basis for understanding pathological alterations

Ultrastructural Pathology

Volumn 30, Issue 6, 2006, Pages 471-479

  Herrera, Guillermo A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glomerular pathology; Glomerulus; Matrix; Mesangial cells; Mesangial matrix; Mesangium

Indexed keywords

BONE MARROW CELL; CELL DAMAGE; CELL DIFFERENTIATION; CELL FUNCTION; CELL REGENERATION; EXTRACELLULAR MATRIX; GLOMERULAR STRUCTURE; GLOMERULOPATHY; HOMEOSTASIS; KIDNEY DISEASE; MESANGIUM CELL; PLASTICITY; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX; HUMANS; KIDNEY DISEASES; MESANGIAL CELLS;

EID: 33845906068     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.1080/01913120600932594     Document Type: Review

References (70)

1. Key EA. On circulations for hallendena i. Njurarne. Forh v. de skandin. Ńaturf. Stockholm, 1865; 685-725.
2. Zimmermann KW. Über den Bau des Glomerulus der Säugerniere. Ztschr. f. mikr.-anat. Forsch. 1933;32:176-278.
3. Zimmermann KW. Über den Bau des Glomerulus der menschlichen Niere. Ztschr.f.mikr.-anat. Forsch. 1929;18:520-552.
4. Goormaghtigh. N. La doctrine de la cellule musculaire, afibrillaire, endocrine en pathologie humaine. 2. Le rein de l'eclampsie puerperale. Bull Acad R Med Belgique. 1942;7(s.6):194-216.
5. Olivetti G, Anversa P, Rigamonti W, Vitali-Mazza L, Loud AV. Morphometry of the renal corpuscle during normal postnatal growth and compensatory hypertrophy: a light microscope study. J Cell Biol. 1977;75:573-585.
6. Latta H, Maunsbach AB. Relations of the centrolobular region of the glomerulus to the juxtaglomerular apparatus. J Ultrastruct Res. 1962;6:562-578.
7. Borst JGG. Der Bau des normalen Glomerulus. Zuchr. f. mikr.-anat. Forsch. 1931;23:455-483.
8. Kimmelstiel P, Wilson C. Intercapillary lesions in the glomeruli of the kidney. Am J Pathol. 1936;12:83-106.
9. Latta H. Maunsbach AB, Madden SC. The centrolobular region of the renal glomerulus studied by electron microscopy. J Ultrastruct Res. 1960;4:455-472.
10. Farquhar MG, Palade GE. Functional evidence for the existence of a third cell type in the renal glomerulus: phagocytosis of filtration residues by a distinctive "third" cell. J Cell Biol. 1962;13:55-87.
11. McManus JFA. Structure of the glomerulus of the huamn kidney. Am J Pathol. 1948;24:1259-1269.
12. Pease DC. Fine structures of the kidney seen by electron microscopy. J Histochem Cytochem. 1955;3:295-308.
13. Bergstrand A. Electron microscopic investigations of the renal glomeruli. Lab Invest. 1957;6:191-204.
14. Pak Poy RK. Electron microscopy of the mammalian renal glomerulus; the problems of intercapillary tissue and the capillary loop basement membrane. Am J Pathol. 1958;34:885-895.
15. Mueller CB, Mason AD Jr, Stout DG. Anatomy of the glomerulus. Am J Med. 1955;18:267-276.
16. Couchman JR, Beavan LA, McCarthy KJ. Glomerular matrix: synthesis, turnover and role in mesangial expansion. Kidney Int. 1994;45:328-335.
17. Kitamura M. Mitarai T, Maruyama N, Nagasawa R, Yoshida H, Sakai O. Mesangial cell behavior in a three-dimensional extracellular matrix. Kidney Int. 1991;40:653-661.
18. Sedor JR, Konieczkowski M, Huang S, et al. Cytokines, mesangial cell activation and glomerular injury. Kidney Int Suppl. 1993;39:S65-S70.
19. Silver BJ, Jaffer FE, Abboud HE. Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens. Proc Natl Acad Sci USA. 1989;86:1056-1060.
20. Schlondorff D. The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J. 1987;1:272-281.
21. Kreisberg JI, Venkatachalam M, Troyer D. Contractile properties of cultured glomerular mesangial cells. Am J Physiol. 1985;249:F457-F463.
22. Schreiner GF. Unanue ER. Origin of the rat mesangial phagocyte and its expression of the leukocyte common antigen. Lab Invest. 1984;51:515-523.
23. Schreiner GF. The mesangial phagocyte and its regulation of contractile cell biology. J Am Soc Nephrol. 1992;2:S74-S82.
24. Sorokin L, Ekblom P. Development of tubular and glomerular cells of the kidney. Kidney Int. 1992;41:657-664.
25. Holthöfer H, Sainio K, Miettinen A. The glomerular mesangium: studies of its developmental origin and markers in vivo and in vitro. APMIS. 1995;103:354-366.
26. Keeling J, Teng J, Herrera GA. AL-amyloidosis and light chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells. Lab Invest. 2004;84:1322-1338.
27. Kriz W, Elger M, Lemley K, Sakai T. Structure of the glomerular mesangium: a biomechanical interpretation. Kidney Int. 1990;30:S2-S9.
28. Truong LD, Majesky MW, Pindur J. Tenascin is synthesized and secreted by rat mesangial cells in culture and is present in extracellular matrix in human glomerular diseases. J Am Soc Nephrol. 1994;4:1771-1777.
29. Ooi BS, Cohen DJ, Veis JH. Biology of the mesangial cell in glomerulonephritis: role of cytokines. Proc Soc Exp Biol Med. 1996;213:230-237.
30. Sedor JR. Cyokines and growth factors in renal injury. Semin Nephrol. 1992;12:428-440.
31. Roberts AB, McCune BK, Sporn MB. TGF-β: regulation of extracellular matrix. Kidney Int. 1992;41:557-559.
32. Border WA, Okuda S, Languino LR, Ruoslahti E. Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int. 1990;37:689-695.
33. Davies M, Martin J, Thomas GJ, Lovett DH. Proteinases and glomerular matrix turnover. Kidney Int. 1992;41:671-678.
34. Bode W, Fernandez-Catalan C, Tschesche H, Grams F, Nagase H, Maskos K. Structural properties of matrix metalloproteinases. Cell Mol Life Sci. 1999;55:639-652.
35. Saito K, Shimizu F, Sato T, Oite T. Moudulation of human mesangial cell behaviour by extracellular matrix components: the possible role of interstitial type III collagen. Clin Exp Immmunol. 1993;91:510-515.
36. Martin J, Eynstone L, Davies M, Steadman R. Induction of metalloproteinases by glomerular mesangial cells stimulated by proteins of the extracellular matrix. J Am Soc Nephrol. 2001;12:88-96.
37. Cosio FG, Sedmak DD. Nahman NS Jr. Cellular receptors for matrix proteins in normal human kidney and human mesangial cells. Kidney Int. 1990;38:886-895.
38. Gomez-Guerrero C, Duque N, Egido J. Mesangial cells possess an asialoglycoprotein receptor with affinity for human immunoglobulin A. J Am Soc Nephrol. 1998;9:568-576.
39. Lopez-Armada MJ, Gomez-Guerrero C, Egido J. Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta. J Immunol. 1996;157:2136-2142.
40. Moura IC, Arcos-Fajardo M, Sadaka C, et al. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol. 2004;15:622-634.
41. Knauss TC, Méne P, Ricanati SA, et al. Immune complex activation of rat glomerular mesangial cells: dependence on the Fc region of antibody. Am J Phys. 1989;257:F478-F485.
42. Russell WJ, Cardelli J, Harris E, Baier RJ, Herrera GA. Monoclonal light chain: mesangial cell interactions: early signaling events and subsequent pathologic effects. Lab Invest. 2001;81:689-703.
43. Abboud HE. Platelet-derived growth factor and mesangial cells. Kidney Int. 1992;41:581-583.
44. Gesualdo L, Ranieri E, Pannarale G, Di Paolo S, Schena FP. Platelet-derived growth factor and proliferative glomerulonephritis. Kidney Int. 1993;39:S86-S89.
45. Moses HL, Yang EY, Pietenpol JA. TFG-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell. 1990;63:245-247.
46. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massague J. Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation. Cell. 1990;62:175-185.
47. Keeling J, Herrera GA. Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage. Kidney Int. 2005;58:1590-1603.
48. Yamamoto T, Noble NA, Miller DE, Border WA. Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int. 1994;45:916-927.
49. Striker LJ, Doi T, Elliot S, Striker GE. The contribution of glomerular mesangial cells to progressive glomerulosclerosis. Semin Nephrol. 1989;9:318-328.
50. Border WA, Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest. 1992;90:1-7.
51. El-Nahas AM. Plasticity of kidney cells: role in kidney remodeling and scarring. Kidney Int. 2003;64:1553-1563.
52. Johnson RJ, Floege J, Yoshimura A, Iida H, Couser WG, Alpers CE. The activated mesangial cell: a glomerular "myofibroblast"? J Am Soc Nephrol. 1992;2:S190-S197.
53. Patel K, Harding P, Haney LB, Glass WF II. Regulation of the mesangial cell myofibroblast phenotype by actin polymerization. J Cell Physiol. 2003;195:435-445.
54. Johnson RJ, Iida H, Alpers CE, et al. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis: alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest. 1991;87:847-858.
55. Teng J, Russell WJ, Gu X, Cardelli J, Jones ML, Herrera GA. Different types of glomerulopathic light chains interact with mesangial cells using a common receptor byt exhibit different intracellular trafficking patterns. Lab Invest. 2004;84:440-451.
56. Bencosme SA, Stone RS, Latta H, Madden SC. Acute reactions with collagen production in renal glomeruli of rats as studied electron microscopically. J Ultrastruct Res. 1959;3:171-185.
57. Turbat-Herrera EA, Isaac J, Sanders PW, Truong LD, Herrera GA. Integrated expression of glomerular extracellular matrix proteins and beta 1 integrins in monoclonal light chain-related renal diseases. Mod Pathol. 1997;10:485-495.
58. Sakamura T, Kusano I. Tenascin in tissue perturbation repair. Acta Pathol Jpn. 1991;41:247-258.
59. Kuhn C, Mason RJ. Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am J Pathol. 1995;147:1759-1769.
60. Imai K, Kusakabe M, Sakakura T, Nakanishi I, Okada Y. Susceptibility of tenascin to degradation by matrix metalloproteinases and serine proteinases. FEBS Lett. 1994;352:216-218.
61. Zhu L, Herera GA, Murphy-Ullrich JE, Huang ZQ, Sanders PW. Pathogenesis of glomerulosclerosis in light chain deposition disease: role for transforming growth factor-β. Am J Pathol. 1995;147:375-385.
62. Herrera GA, Russell WJ, Isaac J, et al. Glomerulopathic light chain-mesangial cell interactions modulate in vitro extracellular matrix remodeling and reproduce mesangiopathic findings documented in vivo. Ultrastruct Pathol. 1999;23:107-126.
63. Isaac J, Kerby JD, Russell WJ, Dempsey SC, Sanders PW, Herrera GA. In vitro modulation of AL-amyloid formation by human mesangial cells exposed to amyloidogenic light chains. Amyloid. 1998;5:238-246.
64. Lipkowitz MS, Klotman ME, Bruggeman LA, et al. Molecular therapy for renal diseases. Am J Kidney Dis. 1996;28:475-492.
65. Bottinger EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol. 2002;13:2600-2610.
66. Masaki T, Stambe C, Hill PA, Dowling J, Atkins RC, Nikolic-Paterson DJ. Activation of the extracellular-signal regulated protein kinase pathway in human glomerulopathies. J Am Soc Nephrol. 2004;15:1835-1843.
67. Basile DP. Transforming growth factor-β as a target for treatment in diabetic nephropathy. Am J Kidney Dis. 2001;38:887-892.
68. Heidland A, Sebekova K, Paczek L, Teschner M, Dämmrich J, Gaciong Z, Renal fibrosis: role of impaired proteolysis and potential therapeutic strategies. Kindney Int. 1997;52:S32-S35.
69. Ito T, Suzuki A, Imai E, Okabe M, Hori M. Bone marrow is a reservoir of repopulating mesangial cell during glomerular remodeling. J Am Soc Nephrol. 2001;12:2665-2635.
70. Imasawa T, Utsunomiya Y, Kawamura T, et al. The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J Am Soc Nephrol. 2001;12:1401-1409.